Evidence map›Paper›PMID 41784364›Full record

ArticleJournal of clinical microbiology2026

Poloxamer dilution as an on-demand alternative to agar dilution-based antimicrobial susceptibility testing.

Matthew T J Uy, Andrea Kirmaier, Lindsey M Rudtner, Aidan Pine, James E Kirby

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthew T J UyBeth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Andrea Kirmaier *Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Lindsey M Rudtner *Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Aidan PineBeth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
James E KirbyBeth Israel Deaconess Medical Center, Boston, Massachusetts, USA.ORCID 0000-0003-0392-4500

Funding

Massachusetts Life Science Center Novel Therapeutics Delivery GrantNortheastern University Carole Shapazian Research Co-op Fellowship
6 · The paper itself

Abstract

Agar dilution is a reference susceptibility testing method uniquely or preferentially recommended for certain antimicrobials. However, the effort required to pour individual agar plates spanning a doubling dilution range precludes its practical implementation in hospital clinical laboratories. Here, we describe an on-demand replacement for agar dilution, specifically substituting Poloxamer 407 (also known as Pluronic F-127) for Bacto agar as the solidifying agent. Notably, 20% Poloxamer 407 solutions (e.g., with Mueller-Hinton broth) remain liquid at refrigerated temperatures but solidify upon warming, enabling facile setup of poloxamer dilution testing in Petri dish or microwell format. For fosfomycin susceptibility testing, poloxamer dilution and reference agar dilution showed excellent categorical agreement (CA) and essential agreement (EA) for IMPORTANCE: Accurate antibiotic susceptibility testing is essential for guiding treatment of bacterial infections. For the antibiotic fosfomycin, used to treat

Indexed as

Anti-Bacterial AgentsPoloxamerAgarCulture MediaHumansMicrobial Sensitivity TestsAgarAnti-Bacterial AgentsCulture MediaPoloxameragar dilutionantimicrobial susceptibility testingclinical microbiology laboratoryEnterobacteralesfosfomycingram-negative bacteriaMueller–Hinton mediumPluronic F-127Poloxamer 407Pseudomonas aeruginosa

Identifiers

PMID41784364
PMCPMC13059702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.